- $2.02m
- -$0.13m
- $18.32m
- 55
- 100
- 30
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.11 | ||
| Price to Tang. Book | 0.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.12 | ||
| EV to EBITDA | 0.03 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.68% | ||
| Return on Equity | 7.49% | ||
| Operating Margin | 9.5% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 12.12 | 21.75 | 27.73 | 20.11 | 18.32 | n/a | n/a | 41.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +0.04 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Trucept, Inc. provides marketing, accounting and human resource services to a range of industries, including staffing, professional employment organizations and hospitality. It has two subsidiaries. Afinida Inc. offers various services, including payroll services, which includes payroll processing, cloud-based software, direct deposits, new hire reporting and others, and payroll tax services, which includes payroll tax payments, filings and compliance services. Afinida Insurance Services, Inc. offers employee benefits, which include medical/dental/vision plans, supplemental insurance, and life insurance and cafeteria plans; commercial lines, which includes workers' compensation, business owners’ policies, property insurance, general liability insurance and employment practices liability insurance; and individual policies, which includes medical, dental and vision plans, supplemental insurance, life insurance and home owners/condo/renters insurance.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- March 22nd, 1995
- Public Since
- May 2nd, 1996
- No. of Employees
- 28
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 56,098,460
- Address
- 600 La Terraza Blvd, ESCONDIDO, 92025
- Web
- https://trucept.com/
- Phone
- +1 8587981644
- Auditors
- PMB Helin Donovan, LLP
Upcoming Events for TREP
Q3 2024 Trucept Inc Earnings Release
Similar to TREP
1PM Industries
Pink Sheets on Nasdaq
3Dshopping.Com
Pink Sheets on Nasdaq
3 Sixty Risk Solutions
Pink Sheets on Nasdaq
ACS Global
Pink Sheets on Nasdaq
Adecco AG
Pink Sheets on Nasdaq
FAQ
What is the Trucept share price?
As of Today at 23:50 UTC, shares in Trucept are trading at $0.04. This share price information is delayed by 15 minutes.
How has the Trucept share price performed this year?
Shares in Trucept last closed at $0.04 and the price had moved by -12.24% over the past 365 days. In terms of relative price strength the Trucept share price has underperformed the S&P500 Index by -26.34% over the past year.
What are the analyst and broker recommendations for Trucept?
There is no consensus recommendation for this security.
What is the Trucept dividend yield?
Trucept does not currently pay a dividend.
Does Trucept pay a dividend?
Trucept does not currently pay a dividend.
When does Trucept next pay dividends?
Trucept does not currently pay a dividend.
How do I buy Trucept shares?
To buy shares in Trucept you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Trucept?
As of the previous close price of $0.04, shares in Trucept had a market capitalisation of $2.21m.
Where are Trucept shares listed?
Here are the trading details for Trucept:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TREP
What kind of share is Trucept?
Based on an overall assessment of its quality, value and momentum Trucept is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Trucept share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Trucept share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trucept. Over the past six months, its share price has underperformed the S&P500 Index by -25.42%.
As of the last closing price of $0.04, shares in Trucept were trading -5.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Trucept PE Ratio?
The Trucept PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Trucept?
Trucept's management team is headed by:
- Brian Bonar - CHM
- Norman Tipton - CEO
- Owen Naccarato - DRC
- Julie Neill - DRC